• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On RANBAXY.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Ranbaxy Laboratories Ltd. (RANBAXY.BO)

    -BSE
    617.45 Down 3.10(0.50%) Dec 19, 5:29AM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (12,110,000) (10,116,000) 9,228,000   (28,997,000)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation3,198,000   -  3,000,000  2,903,000  
    Adjustments To Net Income -   -   -   -  
    Changes In Accounts Receivables646,000   -  10,857,000  (11,707,000)
    Changes In Liabilities -   -   -   -  
    Changes In Inventories148,000   -  (882,000)(3,097,000)
    Changes In Other Operating Activities(440,000) -  1,082,000  (1,087,000)
    Total Cash Flow From Operating Activities (28,499,000) -   15,821,000   6,388,000  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(6,247,000) -  (4,767,000)(4,773,000)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities 14,656,000   -   (18,203,000) 16,687,000  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock -   -   -   -  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities20,843,000   -  (13,533,000)20,951,000  
    Total Cash Flows From Financing Activities 8,129,000   -   2,369,000   (12,177,000)
    Effect Of Exchange Rate Changes1,009,000   -  (510,000)1,119,000  
    Change In Cash and Cash Equivalents (4,705,000) -   (523,000) 12,017,000  

    Currency in INR.